Current and Emerging Pharmacotherapies for Cessation of Tobacco Smoking

Author:

Gómez-Coronado Nieves1,Walker Adam J.2,Berk Michael23456,Dodd Seetal2345ORCID

Affiliation:

1. Unidad de Gestión Clinica Salud Mental; Hospital Universitario Virgen del Rocio; Sevilla Spain

2. IMPACT Strategic Research Centre; Deakin University; Geelong Victoria Australia

3. Barwon Health; University Hospital Geelong; Geelong Victoria Australia

4. Department of Psychiatry; The University of Melbourne; Parkville Victoria Australia

5. Orygen, the National Centre of Excellence in Youth Mental Health; Parkville Victoria Australia

6. Florey Institute of Neuroscience and Mental Health; Parkville Victoria Australia

Publisher

Wiley

Subject

Pharmacology (medical)

Reference113 articles.

1. A clinical practice guideline for treating tobacco use and dependence: 2008 update. A U.S. Public Health Service report;Clinical Practice Guideline Treating Tobacco Use and Dependence 2008 Update Panel, Liaisons, and Staff;Am J Prev Med,2008

2. Nicotine receptor partial agonists for smoking cessation;Cahill;Cochrane Database Syst Rev,2016

3. New pharmacological agents to aid smoking cessation and tobacco harm reduction: what has been investigated, and what is in the pipeline?;Beard;CNS Drugs,2016

4. Emerging drugs for the treatment of tobacco dependence: 2014 update;Elrashidi;Expert Opin Emerg Drugs,2014

5. Non-nicotine pharmacotherapy for smoking cessation;Benowitz;CNS Drugs,2000

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3